Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/16/2023 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 5.1k | $2.10 | $10.7k | | 06/16/2023 |
05/16/2023 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 16.5k | $1.82 | $30k | | 05/16/2023 |
05/03/2023 | ZEVRA THERAPEUTICS, INC. | KMPH | Grant | Stock Option (right to buy) | 36.3k | $0.00 | $0 | | 04/25/2023 |
04/25/2023 | ZEVRA THERAPEUTICS, INC. | KMPH | Grant | Stock Option (right to buy) | 22.5k | $0.00 | $0 | | 04/25/2023 |
03/16/2023 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 6.4k | $1.67 | $10.7k | | 03/16/2023 |
12/16/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 7.2k | $1.50 | $10.8k | | 12/16/2022 |
09/16/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 4.1k | $2.62 | $10.7k | | 09/16/2022 |
06/17/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 4.9k | $2.03 | $10k | | 06/17/2022 |
06/17/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 4.1k | $2.03 | $8.2k | | 06/17/2022 |
06/16/2022 | ARVINAS, INC. | ARVN | Grant | Stock Option (right to buy) | 10.2k | $36.79 | $375k | | 06/16/2022 |
06/14/2022 | Alkermes plc. | ALKS | Exercise | Restricted Stock Unit Award | 7.6k | $0.00 | $0 | | 06/14/2022 |
06/10/2022 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | Grant | Deferred Restricted Stock Unit | 51.2k | $0.00 | $0 | | 06/10/2022 |
06/10/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | | 06/10/2022 |
04/06/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 30k | $3.04 | $91.2k | | 04/06/2022 |
03/31/2022 | INCYTE CORP | INCY | Grant | | 249 | $79.42 | $19.8k | | 03/31/2022 |
12/31/2021 | INCYTE CORP | INCY | Grant | | 260 | $73.40 | $19.1k | | 12/31/2021 |
12/23/2021 | INCYTE CORP | INCY | Sale | Common Stock | 20k | $22.05 | $441k | | 12/23/2021 |
12/23/2021 | INCYTE CORP | INCY | Exercise | Non Qualfied Stock Option (right to buy) | 20k | $73.25 | $1.5M | | 12/23/2021 |
12/02/2021 | Alkermes plc. | ALKS | Payment of Exercise | Ordinary Shares | 1.3k | $22.11 | $29.6k | | 12/02/2021 |
12/02/2021 | Alkermes plc. | ALKS | Exercise | Restricted Stock Unit Award | 5.6k | $0.00 | $0 | | 12/02/2021 |
11/11/2021 | bluebird bio, Inc. | BLUE | Other (disposition) | Stock Option (right to buy) | 5k | $0.00 | $0 | | 11/11/2021 |
11/11/2021 | bluebird bio, Inc. | BLUE | Other (acquisition) | | 6.2k | $0.00 | $0 | | 11/11/2021 |
11/11/2021 | bluebird bio, Inc. | BLUE | Other (disposition) | Stock Option (right to buy) | 26.4k | $0.00 | $0 | | 11/11/2021 |
11/11/2021 | bluebird bio, Inc. | BLUE | Other (disposition) | Stock Option (right to buy) | 7.5k | $0.00 | $0 | | 11/11/2021 |
11/11/2021 | bluebird bio, Inc. | BLUE | Other (disposition) | Stock Option (right to buy) | 4k | $0.00 | $0 | | 11/11/2021 |
11/11/2021 | bluebird bio, Inc. | BLUE | Other (disposition) | Stock Option (right to buy) | 3k | $0.00 | $0 | | 11/11/2021 |
09/30/2021 | INCYTE CORP | INCY | Grant | | 244 | $68.78 | $16.8k | | 09/30/2021 |
06/15/2021 | bluebird bio, Inc. | BLUE | Grant | | 3.1k | $0.00 | $0 | | 06/15/2021 |
06/15/2021 | bluebird bio, Inc. | BLUE | Grant | Stock Option (right to buy) | 5k | $32.83 | $164.2k | | 06/15/2021 |
06/14/2021 | Alkermes plc. | ALKS | Grant | Non Qualified Stock Option (Right to Buy) | 15.7k | $24.72 | $387.5k | | 06/14/2021 |
06/14/2021 | Alkermes plc. | ALKS | Grant | Restricted Stock Unit Award | 7.6k | $0.00 | $0 | | 06/14/2021 |
06/10/2021 | Alkermes plc. | ALKS | Sale | Ordinary Shares | 25k | $25.00 | $625k | | 06/10/2021 |
06/10/2021 | Alkermes plc. | ALKS | Exercise | Non Qualified Stock Option (Right to Buy) | 25k | $18.21 | $455.2k | | 06/10/2021 |
06/08/2021 | ARVINAS, INC. | ARVN | Grant | Stock Option (right to buy) | 7.5k | $78.53 | $589.8k | | 06/08/2021 |
05/26/2021 | INCYTE CORP | INCY | Grant | Non-Qualified Stock Option (right to buy) | 8k | $83.16 | $666.1k | | 05/26/2021 |
|